Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	3.19	0.87	1.18	2.1
Cash & Short-Term Investments	3.19	0.87	1.18	2.1
Cash Growth	260.40%	-26.11%	-43.84%	-
Prepaid Expenses	0.2	0.23	0.02	0.02
Total Current Assets	3.39	1.1	1.2	2.13
Property, Plant & Equipment	0.1	0.12	0.03	0.08
Other Intangible Assets	0.83	0.82	0.77	0.7
Other Long-Term Assets	0.01	0.01	0.01	0.01
Total Assets	4.33	2.05	2.01	2.91
Accounts Payable	1.02	0.67	0.46	0.26
Current Portion of Leases	0.04	0.04	0.03	0.05
Current Unearned Revenue	-	-	-	1.42
Total Current Liabilities	1.06	0.71	0.49	1.72
Long-Term Leases	0.06	0.08	-	0.03
Long-Term Unearned Revenue	1.44	1.44	1.44	-
Total Liabilities	2.56	2.23	1.93	1.76
Common Stock	0	0	0	0
Additional Paid-In Capital	23.19	19.02	17.51	18.37
Retained Earnings	-20.76	-19.2	-17.43	-17.22
Shareholders' Equity	1.77	-0.18	0.09	1.16
Total Liabilities & Equity	4.33	2.05	2.01	2.91
Total Debt	0.1	0.12	0.03	0.08
Net Cash (Debt)	3.09	0.75	1.16	2.02
Net Cash Growth	252.35%	-34.98%	-42.76%	-
Net Cash Per Share	0.11	0.03	0.04	-
Filing Date Shares Outstanding	28.02	26.85	26.49	-
Total Common Shares Outstanding	28.02	26.85	26.49	-
Working Capital	2.33	0.39	0.71	0.4
Book Value Per Share	0.06	-0.01	0.00	-
Tangible Book Value	0.95	-1	-0.68	0.46
Tangible Book Value Per Share	0.03	-0.04	-0.03	-
Machinery	-	-	-	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q